Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
NSUN5C Antibody
NCTP08393
Description: Rabbit polyclonal to human NSUN5C
Application: ELISA, IHC
Reactivity: Human
Catalog #: NCTP08393
$360.00
1000 Items
Overview
| DESCRIPTION | |
| Species Reactivity | Human. Predicted: rat and mouse. Other species not tested. |
| Isotype | IgG |
| Immunogen | Recombinant human NSUN5C protein 169-313aa. |
| Accession # | Q63ZY6 |
| Alternative Names | Putative methyltransferase NSUN5C, NOL1/NOP2/Sun domain family member 5C, Williams-Beuren syndrome chromosomal region 20C protein, NSUN5P2, WBSCR20B, WBSCR20C |
| Purification | Purified by protein A column.. |
| Formulation | Lyophilized with 0.02% NaN3. |
| Size | 200µl |
| APPLICATION | |
| ELISA | 1:20,000 – 1: 80,000 |
| Immunohistochemistry | 1:100-1:500 |
| - | For research use only. Optimal dilutions/concentrations should be determined by each laboratory for each application. |
| PREPARATION AND STORAGE | |
| Reconstitution | Reconstitute in 200µl of sterile H2O. |
| Storage | Shipped at ambient temperature. Store immediately at -20°C upon receipt. Avoid repeated freeze-thaw cycles. |
| REFERENCES | |
| - | Merla G., Ucla C., Guipponi M., et al. Identification of additional transcripts in the Williams-Beuren syndrome critical region. Hum. Genet. 110:429-438(2002). |